Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Janssen India MD To Depart

Wed, 04/17/2019 - 8:56am

Significant leadership change is underway at J&J India, with Janssen India chief Sanjiv Navangul on his way out. He will...

      Related Stories 

Further Iclaprim Analyses Ahead Of Crucial Months For Motif Bio

Wed, 04/17/2019 - 4:38am

A 3 May meeting with the FDA is likely to be crucial for the future commercialization strategy for the biotech’s...

      Related Stories 

CHART/TABLE: Executives On The Move: VPs Exit Pfizer And Janssen For New Posts, And Royal DSM Chooses New President

Wed, 04/17/2019 - 3:26am

US affiliate of Japanese pharma Astellas taps Pfizer exec for its SVP and Head, Medical Affairs and synthetic biotherapeutics firm...

      Related Stories 

CymaBay Following The Leaders, Pursues NASH, PBC Simultaneously

Tue, 04/16/2019 - 2:06pm

Biotech thinks its PPAR delta agonist will prove much more potent than Genfit’s elafibranor from the same class and will...

      Related Stories 

NASH News & Notes From The European Liver Meeting

Tue, 04/16/2019 - 1:51pm

Non-alcoholic steatohepatitis (NASH) was a focal point of EASL’s conference. Madrigal becomes the fifth company into Phase III in NASH...

      Related Stories 

J&J's Spravato's Star Power Rises While Zytiga's Sets

Tue, 04/16/2019 - 1:29pm

With Spravato's launch underway, J&J reports that 800 sites have been certified to administer the depression drug. Newer drugs drove...

      Related Stories 

Annuity-Based Pricing Models Could Mean Problems For Small Biotechs

Tue, 04/16/2019 - 8:26am

Interest in annuity payment models is growing among companies and payers, but such models could be risk financial viability of...

      Related Stories 

India New Trial Rules - Sponsors Interested But 'FAQ' Could Help

Tue, 04/16/2019 - 6:37am

India’s new clinical trial regulations could revive sponsor interest in the country, but some norms around local Phase III trial...

      Related Stories 

Cassiopea Hails Breezula's 'Good Hair Day' And Plans FDA Talks On Phase III

Tue, 04/16/2019 - 6:12am

Italy-based Cassiopea says “very positive results” from Breezula's 12-month Phase II alopecia trial support progressing  it to Phase III, particularly given...

      Related Stories 

Hansa Raises More Cash For Pipeline With Genovis Stake Sale

Tue, 04/16/2019 - 2:04am

The Swedish group has sold its stake in Genovis, raising about $9.6m that will help advance lead candidate imlifidase.

      Related Stories 

Pfizer Thinks First-In-Class KHK Mechanism Could Work For NASH, Diabetes

Mon, 04/15/2019 - 1:55pm

Pfizer has high hopes for ketohexokinase inhibition and other fat-reducing mechanisms in NASH. Data from a small study reported at...

      Related Stories 

Gelesis's Obesity Product FDA Acceptance Gives Boost To PureTech's Portfolio

Mon, 04/15/2019 - 8:36am

PureTech's affiliate Gelesis has received FDA clearance for its Plenity capsule to treat overweight-obese adults, and plans to launch it...

      Related Stories 

Product Sales, Pipeline & Biosimilar Timelines Key Themes For Roche 1Q

Mon, 04/15/2019 - 6:52am

Investors during Roche’s first-quarter update Wednesday will be looking for clues on looming biosimilar competition and timelines for the emergence...

      Related Stories 

CHART/TABLE: Pipeline Watch: Promising Clinical Trial Results In NASH

Mon, 04/15/2019 - 2:14am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

M&A A Major Pillar Of Sumitomo Dainippon's New Mid-Term Plan

Sun, 04/14/2019 - 10:17pm

Mid-size Japanese player Sumitomo Dainippon sets aside billions for potential M&A deals under a new business plan designed to fill...

      Related Stories 

Sun US Chief Settles Insider Trading Case

Sun, 04/14/2019 - 4:49pm

Top Sun Pharma executive Abhay Gandhi and his wife have settled a case pertaining to alleged insider trading in shares...

      Related Stories 

Pages